the Effect of Environmental Factors on Colorectal Cancer Based on Macrogenomes
NCT ID: NCT06852495
Last Updated: 2025-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
200 participants
OBSERVATIONAL
2024-11-01
2027-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
the colorectal cancer group
patients diagnosed with colorectal cancer
No interventions assigned to this group
the control group
Healthy individuals with no history of malignant tumor
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with colorectal cancer by pathologic biopsy before surgery;
* Patients did not undergo chemotherapy, radiotherapy, targeted and immunotherapy, etc. before enrollment;
* Willing to participate in the study and sign an informed consent form. Complete clinical data.
Exclusion Criteria
* Patients with severe cardiopulmonary insufficiency or other systemic diseases that affect the choice of treatment plan;
* Inappropriate for enrollment as assessed by the investigator;
* Incomplete clinical data.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dong Peng
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dong Peng
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-443-01
Identifier Type: -
Identifier Source: org_study_id